# An atlas of cGAS-STING signaling in pathophysiological angiogenesis and retinal vascular homeostasis across species

**Authors:** Xuemin He, Rui Zeng, Siying Wen, Zheyao Wen, Hejun Li, Heying Ai, Rong Gao, Liwen Fan, Li Zhou, Guojun Shi, Yanming Chen, Shasha Li

PMC · DOI: 10.1016/j.omtn.2026.102847 · Molecular Therapy. Nucleic Acids · 2026-01-24

## TL;DR

This study shows that the cGAS-STING signaling pathway is linked to blood vessel growth in the retina across multiple species, offering a new target for treating vision loss.

## Contribution

The study reveals a conserved interaction between cGAS-STING and VEGFA-VEGFR2 signaling in retinal angiogenesis across species.

## Key findings

- cGAS-STING signaling correlates with angiogenesis in retinal endothelia across species.
- STING1 deletion in mice and human cells reduces VEGFR2 activation and endothelial function.
- STING1 overexpression counteracts the effects of deletion, confirming its role in vascular growth.

## Abstract

Abnormal angiogenesis is the leading cause of vision loss globally, but current anti-angiogenic treatments are unsatisfactory and incompetent. Thus, novel therapies targeting angiogenesis are urgently needed. Previously, we revealed a positive association between cGAS-STING signaling and angiogenic factors in the mouse model with ischemic retinopathy. However, whether cGAS-STING signaling regulates retinal angiogenesis remained largely unknown. Here, we analyzed single-cell RNA sequencing databases from the epiretinal fibrovascular membranes, developing mouse retinas, and normal adult retinas from Homo sapiens, Sus scrofa, and Macaca. Notably, we observed spatially and temporally identical expression patterns of cGAS-STING signaling and angiogenesis. In particular, cGAS-STING signaling showed the strongest correlation with angiogenesis in retinal endothelia from mice at postnatal days 3 and 6. Endothelia-specific knockout of Sting1 in mice retarded retinal vascular growth, which was due to attenuation of VEGFA-VEGFR2 signaling as suggested by bulk RNA sequencing. In human retinal vascular endothelial cells, deletion of STING1 prohibited VEGFR2 activation, down-regulated the levels of endothelial markers, and compromised endothelial proliferation and migration, which were counteracted by overexpression of STING1. This study demonstrated an evolutionally conserved interaction between cGAS-STING signaling and VEGFA-VEGFR2 signaling in pathophysiological angiogenesis and vascular homeostasis, thus providing a novel therapeutic target for treating retinal vascular diseases.

Endothelial cGAS-STING signaling displays a conserved interaction with the VEGFA-VEGFR2 cascade in pathophysiological angiogenesis and retinal vascular homeostasis across species. Activation of STING induced the transcription of KDR and VEGFA to promote endothelial migration and proliferation, providing a novel regulatory mechanism and therapeutic target for ocular angiogenic diseases.

## Linked entities

- **Genes:** CGAS (cyclic GMP-AMP synthase) [NCBI Gene 115004], STING1 (stimulator of interferon response cGAMP interactor 1) [NCBI Gene 340061], STING1 (stimulator of interferon response cGAMP interactor 1) [NCBI Gene 340061], VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422], KDR (kinase insert domain receptor) [NCBI Gene 3791], KDR (kinase insert domain receptor) [NCBI Gene 3791], STING1 (stimulator of interferon response cGAMP interactor 1) [NCBI Gene 340061]
- **Species:** Homo sapiens (taxon 9606), Sus scrofa (taxon 9823), Macaca (taxon 9539), Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Sting1 (stimulator of interferon response cGAMP interactor 1) [NCBI Gene 72512] {aka 2610307O08Rik, ERIS, MPYS, Mita, STING, STING-beta}, Dll4 (delta like canonical Notch ligand 4) [NCBI Gene 54485] {aka Delta4}, Irf7 (interferon regulatory factor 7) [NCBI Gene 54123], PECAM1 (platelet and endothelial cell adhesion molecule 1) [NCBI Gene 5175] {aka CD31, CD31/EndoCAM, GPIIA', PECA1, PECAM-1, endoCAM}, TBK1 (TANK binding kinase 1) [NCBI Gene 29110] {aka AIARV, FTDALS4, IIAE8, NAK, T2K}, Vegfa (vascular endothelial growth factor A) [NCBI Gene 22339] {aka L-VEGF, Vegf, Vpf}, CGAS (cyclic GMP-AMP synthase) [NCBI Gene 115004] {aka C6orf150, D4, MB21D1, h-cGAS}, Kdr (kinase insert domain protein receptor) [NCBI Gene 16542] {aka 6130401C07, Flk-1, Flk1, Krd-1, Ly73, VEGFR-2}, Cxcr4 (C-X-C motif chemokine receptor 4) [NCBI Gene 12767] {aka CD184, CXC-R4, CXCR-4, Cmkar4, LESTR, PB-CKR}, Col4a1 (collagen, type IV, alpha 1) [NCBI Gene 12826] {aka Bru, Col4a-1, Raw, Svc}, Tgfbr3 (transforming growth factor, beta receptor III) [NCBI Gene 21814] {aka 1110036H20Rik, TBRIII}, IRF3 (interferon regulatory factor 3) [NCBI Gene 3661] {aka IIAE7}, Jun (Jun proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 16476] {aka AP-1, Junc, c-jun}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 21803] {aka TGF-beta1, TGFbeta1, Tgfb, Tgfb-1}, KDR (kinase insert domain receptor) [NCBI Gene 3791] {aka CD309, FLK1, VEGFR, VEGFR2}, Mki67 (antigen identified by monoclonal antibody Ki 67) [NCBI Gene 17345] {aka D630048A14Rik, Ki-67, Ki67}, Pdgfb (platelet derived growth factor subunit B) [NCBI Gene 18591] {aka PDGF-2, PDGF-B, Sis, c-sis}, Tbkbp1 (TBK1 binding protein 1) [NCBI Gene 73174] {aka 3110043L15Rik, ProSAPiP2, SINTBAD}, Rela (Rela proto-oncogene, NFKB subunit) [NCBI Gene 19697] {aka p65, p65 NF-kappa B, p65 NFkB}, Cxcl9 (C-X-C motif chemokine ligand 9) [NCBI Gene 17329] {aka CMK, Mig, MuMIG, Scyb9, crg-10}, Irf3 (interferon regulatory factor 3) [NCBI Gene 54131] {aka C920001K05Rik, IRF-3}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, Ephb2 (Eph receptor B2) [NCBI Gene 13844] {aka Cek5, Drt, ETECK, Erk, Hek5, Nuk}, CDH5 (cadherin 5) [NCBI Gene 1003] {aka 7B4, CD144}, Tjp1 (tight junction protein 1) [NCBI Gene 21872] {aka ZO1}, Pecam1 (platelet/endothelial cell adhesion molecule 1) [NCBI Gene 18613] {aka Cd31, PECAM-1, Pecam}, STING1 (stimulator of interferon response cGAMP interactor 1) [NCBI Gene 340061] {aka ERIS, MITA, MPYS, NET23, SAVI, STING}, Ifi44 (interferon-induced protein 44) [NCBI Gene 99899] {aka A430056A10Rik, MTAP44, p44}, Ifnb1 (interferon beta 1, fibroblast) [NCBI Gene 15977] {aka IFN-beta, IFNB, If1da1, Ifb}, Tek (TEK receptor tyrosine kinase) [NCBI Gene 21687] {aka Cd202b, Hyk, STK1, Tie-2, Tie2}, Flt1 (FMS-like tyrosine kinase 1) [NCBI Gene 14254] {aka Flt-1, VEGFR-1, VEGFR1, sFlt1}, Cldn5 (claudin 5) [NCBI Gene 12741] {aka MBEC1, Tmvcf}, Ifng (interferon gamma) [NCBI Gene 15978] {aka IFN-g, If2f, Ifg}, Ifna (interferon alpha complex region) [NCBI Gene 111654] {aka Ifa, Ifa8}, Ptprc (protein tyrosine phosphatase receptor type C) [NCBI Gene 19264] {aka B220, CD45R, Cd45, L-CA, Ly-5, Lyt-4}, Aplnr (apelin receptor) [NCBI Gene 23796] {aka APJ, Agtrl1, msr/apj}, Cgas (cyclic GMP-AMP synthase) [NCBI Gene 214763] {aka E330016A19Rik, Mb21d1}, RELA (RELA proto-oncogene, NF-kB subunit) [NCBI Gene 5970] {aka AIF3BL3, CMCU, NFKB3, p65}, Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, Akt1 (Akt serine/threonine kinase 1) [NCBI Gene 11651] {aka Akt, LTR-akt, PKB, PKB/Akt, PKBalpha, Rac}
- **Diseases:** vascular dysfunction (MESH:D002561), vascular disruption (MESH:D019958), age-related macular degeneration (MESH:D008268), ischemic (MESH:D002545), diabetic (MESH:D003920), diabetic retinal (MESH:D012173), tumor (MESH:D009369), DR (MESH:D004370), PDR (OMIM:603933), cardiovascular diseases (MESH:D002318), vasculopathy (MESH:D000090122), epiretinal (MESH:D019773), AMD (MESH:D006009), vision loss (MESH:D014786), angiogenic diseases (MESH:D004194), inflammation (MESH:D007249), ocular angiogenic diseases (MESH:D005128), UMAP (MESH:C567162), ischemic retinopathy (MESH:D058437), retinal vascular diseases (MESH:D012164), FVM (MESH:D015433), capillary degeneration (MESH:D009410)
- **Chemicals:** phosphatidylserine (MESH:D010718), Triton X-100 (MESH:D017830), actinomycin-D (MESH:D003609), Actinomyocin-D (-), glucose (MESH:D005947), cycloheximide (MESH:D003513), EdU (MESH:C022811), PBS (MESH:D007854), water (MESH:D014867)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090], Danio rerio (leopard danio, species) [taxon 7955], Sus scrofa (pig, species) [taxon 9823]
- **Mutations:** S2E, 2X, S2, M2, G2
- **Cell lines:** S2H — Homo sapiens (Human), Soft tissue sarcoma, Cancer cell line (CVCL_JB75), HRVEC — Oncorhynchus tshawytscha (Chinook salmon), Spontaneously immortalized cell line (CVCL_DG46), S2F — Mus musculus (Mouse), Hybridoma (CVCL_C4BW), FVM — Homo sapiens (Human), Finite cell line (CVCL_WB24), vascular — Homo sapiens (Human), Finite cell line (CVCL_4009)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12914536/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12914536/full.md

## References

59 references — full list in the complete paper: https://tomesphere.com/paper/PMC12914536/full.md

---
Source: https://tomesphere.com/paper/PMC12914536